CA937866A - Process for the manufacture of a drug dosage form permitting controlled release of active ingredient - Google Patents

Process for the manufacture of a drug dosage form permitting controlled release of active ingredient

Info

Publication number
CA937866A
CA937866A CA095725A CA95725A CA937866A CA 937866 A CA937866 A CA 937866A CA 095725 A CA095725 A CA 095725A CA 95725 A CA95725 A CA 95725A CA 937866 A CA937866 A CA 937866A
Authority
CA
Canada
Prior art keywords
manufacture
active ingredient
dosage form
controlled release
drug dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA095725A
Other languages
English (en)
Inventor
Ross Gerhard
Reul Bernhard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Farbwerke Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farbwerke Hoechst AG filed Critical Farbwerke Hoechst AG
Application granted granted Critical
Publication of CA937866A publication Critical patent/CA937866A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
CA095725A 1969-10-17 1970-10-16 Process for the manufacture of a drug dosage form permitting controlled release of active ingredient Expired CA937866A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691952304 DE1952304A1 (de) 1969-10-17 1969-10-17 Verfahren zur Herstellung einer Arzneiform mit gesteuerter Wirkstoff-Freigabe

Publications (1)

Publication Number Publication Date
CA937866A true CA937866A (en) 1973-12-04

Family

ID=5748430

Family Applications (1)

Application Number Title Priority Date Filing Date
CA095725A Expired CA937866A (en) 1969-10-17 1970-10-16 Process for the manufacture of a drug dosage form permitting controlled release of active ingredient

Country Status (10)

Country Link
AR (1) AR193341A1 (es)
AT (1) AT317433B (es)
BE (1) BE757586A (es)
CA (1) CA937866A (es)
DE (1) DE1952304A1 (es)
ES (1) ES384611A1 (es)
FR (1) FR2070141B1 (es)
GB (1) GB1325742A (es)
NL (1) NL7014922A (es)
ZA (1) ZA707072B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU520409B2 (en) * 1977-05-25 1982-01-28 Commonwealth Scientific And Industrial Research Organisation Controlled release composition
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
GB2118040A (en) * 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
DE3833446A1 (de) * 1988-10-01 1990-04-05 Hoechst Ag Verfahren zur herstellung von arzneimittelwirkstoff-partikeln mit verbesserten fliess-, lager- und formulierungseigenschaften sowie arzneimittel, die diese arzneimittelwirkstoff-partikeln enthalten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1175826B (de) * 1959-10-23 1964-08-13 Olin Mathieson Verfahren zur Herstellung von Arzneipraeparaten zur oralen Verabreichung
GB1073718A (en) * 1964-06-25 1967-06-28 Smith Kline French Lab Improvements relating to the production of sustained-release pharmaceutical pellets
NL7004971A (es) * 1969-04-12 1970-10-14

Also Published As

Publication number Publication date
GB1325742A (en) 1973-08-08
ZA707072B (en) 1971-09-29
NL7014922A (es) 1971-04-20
FR2070141A1 (es) 1971-09-10
AR193341A1 (es) 1973-04-23
BE757586A (fr) 1971-04-15
AT317433B (de) 1974-08-26
ES384611A1 (es) 1973-06-01
DE1952304A1 (de) 1971-05-06
FR2070141B1 (es) 1974-04-12

Similar Documents

Publication Publication Date Title
ZA714095B (en) Bandage for administering drugs
CA930668A (en) Bandage for administering drugs
CA942192A (en) Slow release of anti-inflammatory drug
CA1006060A (en) Device for administration of medicines
IL30329A0 (en) New 13beta-alkyl-9beta,10alpha-pregnanes,methods of producing the same,pharmaceutical compositions comprising the new compounds as an active ingredient and a method of producing these compositions
CA937866A (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
CA952431A (en) Controlled release medicament
FI51765C (fi) Menetelmä säädetyn resorption omaavien kiinteiden lääketuotteiden valm istamiseksi.
CA918668A (en) Pyrazolyl esters, a process for their preparation, and their use as insecticides and acaricides
CA1023293A (en) Process for the preparation of medicinal oils
CA936541A (en) Magnesiummonoaspartate hydrohalogenides, a process for their manufacture and drugs which contain these compounds as active agents
CA707745A (en) Preparation of a medicinal agent for the treatment of hypercholesterolemia
CA810631A (en) Dosage unit forms for the administration of medicaments
NL158504B (nl) Werkwijze ter bereiding van esters van 17 beta-hydroxy-(delta)4-androsteen-3-on, werkwijze ter bereiding van een gedoseerd farmaceutisch preparaat, en voor geneeskundige toediening geschikte vormstukken.
CA770097A (en) Method of preparing sustained release pharmaceutical tablets
CA793863A (en) Process for the preparation of a therapeutic agent
CA806644A (en) Pharmaceutical dosage unit form coating process
CA1024891A (en) Coated retard tablets with exponential release of active ingredient
CA843403A (en) Sustained release medicinal tablets
AU272166B2 (en) Method of preparing sustained release pharmaceutical tablets
CA848999A (en) Process for the preparation of pharmaceutically active new guanidino-alkyl-cycloimines
CA771629A (en) Method of preparing pharmaceutical tablets
AU418935B2 (en) Novel pharmaceutical compositions, and processes for preparing the active ingredient thereof
IL31916A0 (en) Cardioglycoside derivatives of the strophanthidin type,a process for their manufacture and medicinal preparations containing these compounds
CA702065A (en) Process for the preparation of therapeutically active dibenzocycloheptane derivatives